The primary cell market was valued at US$ 1.9 billion in 2021 and is expected to grow at a CAGR of 9.2% through 2032.
Human primary cells are the cells that are isolated directly from the human tissues including the blood and the bone marrow. They are an important tool for in-vitro cell-based assays and also for generating several Vivo models. They are extracted from living tissue and from different living beings also for different purposes. They are often obtained from a biopsy that contains a heterogeneous population of cells that are a representative of the tissue area.
Primary cells are sometimes called mature cells and are also considered to be the most advantageous cells for the human body due to immunological compatibility.
Market Trends
The primary cell market is expected to gain significant growth during the forecast period with the growing demand for monoclonal antibodies which will help in escalating the growth of the primary cell market.
Factors impacting the growth of the primary cell market
The rising frequency of cancer cases, rising cancer research activities, and cancer research funding are all significant factors for the growth of the primary cell market. In terms of any kind of cancer research, primary cells are considered to be the most dominating factor for biomarker discovery and cancer screening Primary human cells also can decrease the expense of the animal models in the economically compatible vivo studies.
Along with that the increasing adoption of stem cell therapy for cancer treatment and treating generic disorders is also propelling the market growth. The increasing adoption of monoclonal antibodies and their application in genetic engineering is also paving the way for the growth of the Primary cell market.
Global Primary Cell Market- Share Analysis, by Geography (2022)
The report titled “Global Primary Cell Market- Global Market Share, Trends, Analysis and Forecasts, 2023-2032” wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the Global Primary Cell Market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
North America dominates the primary cell market owing to the growing occurrence of cancer and its related diseases. Along with that several research and development activities are taking place in the domain which is driving the demand for the primary cells market.
Furthermore, the established healthcare infrastructure is also one of the main factors for the growth of the primary cell market in North America. The report on the Primary Cells market gives a detailed analysis of the market pointing out the market dynamics, market players, and quantitative and qualitative data.
The leading players in this market include Cell Biologics; Stem Cell Technologies; ThermoFisher; American Type Culture Collection; Creative Bio Array; Lonza Group and others.
Market Segmentation
By Product type
By Application
By Geography
The primary cell market was worth US$ 1.9 billion in 2021.
The primary cell market is expected to register a CAGR of 9.2% by 2032.
The rising frequency of cancer cases, rising cancer research activities, and cancer research funding are all significant factors for the growth of the primary cell market.
North America is the principal contributor to the global primary cell market. Rigorous research activities across the region drives the demand for primary cell.
Cell biologics, Stem Cell Technologies, Thermo Fisher Scientific, Lonza Group are few prominent players active in the market.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved